Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis
Study sponsor: Humacyte, Inc. · HUMA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-05-15Actual
Enrollment · participants30Actual
Source updated2024-03-19Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.